Preliminary efficacy assessment of intrathecal injection of an American formulation of adenosine in humans

Anesthesiology

Volumn 96, Issue 1, 2002, Pages 29-34

  Eisenach, James C ^a,b   Hood, David D ^a   Curry, Regina ^a  

^a Department of Anesthesiology ^*

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CAPSAICIN; PLACEBO;

ADULT; ALLODYNIA; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; HUMAN; HYPERALGESIA; HYPERSENSITIVITY; MALE; MECHANICAL STIMULATION; NERVE INJURY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; RISK ASSESSMENT; SENSITIZATION; STIMULUS RESPONSE;

EID: 0036139634     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200201000-00011     Document Type: Article

References (25)

1. Antinociceptive effects in mice after intrathecal injection of 5′-nethylcarboxamide adenosine
2. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat
3. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists
4. Adenosine receptor activation and nociception
5. The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury
6. The efficacy of a novel adenosine agonist (WAG 994) in postoperative dental pain
7. An open label trial of the possible analgesic effects of dipyridamole
8. Adenosine increases the cutaneous heat pain threshold in healthy volunteers
9. Peroperative adenosine infusion reduces the requirements for isoflurane and postoperative analgesics
10. Intrathecal adenosine administration: A phase 1 clinical safety study in healthy volunteers, with additional evaluation of its influence on sensory, thresholds and experimental pain
11. The safety and efficacy of intrathecal adenosine in patients with chronic neuropathic pain
12. Intrathecal adenosine administration in abdominal hysterectomy lacks analgesic effect
13. Phase I safety assessment of intrathecal injection of an American formulation of adenosine in humans
14. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin
15. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects
16. Intrathecal, but not intravenous, clonidine reduces experimental thermal or capsaicin-induced pain and hyperalgesia in normal volunteers
17. AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans
18. Alfentanil, but not amitriptyline, reduces pain, hyperalgesia, and allodynia from intradermal injection of capsaicin in humans
19. Neurogenic hyperalgesia: Central neural correlates in responses of spinothalamic tract neurons
20. Enhanced responses of spinothalamic tract neurons to excitatory amino acids accompany capsaicin-induced sensitization in the monkey
21. Relative potency of epidural to intrathecal clonidine differs between acute thermal pain and capsaicin-induced allodynia
22. Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain
23. Adenosine and neuropathic pain
24. Turnover of adenosine in plasma of human and dog blood
25. Intrathecal adenosine following spinal nerve ligation in rat: Short residence time in cerebrospinal fluid and no change in A, receptor binding